9258 Wealth Management, LLC Abb Vie Inc. Transaction History

9258 Wealth Management, LLC

$664 Million
Q3 2024

A detailed history of 9258 Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, 9258 Wealth Management, LLC holds 17,598 shares of ABBV stock, worth $3.09 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

17,598

Previous 17,536 0.35%

Holding current value

$3.09 Million

Previous $3.01 Million 15.56%

% of portfolio

0.52%

Previous 0.47%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $10,158 - $12,358	62 Added 0.35%	17,598 $3.48 Million
Q2 2024 Aug 02, 2024	BUY	$154.79 - $180.76 $54,640 - $63,808	353 Added 2.05%	17,536 $3.01 Million
Q1 2024 May 03, 2024	BUY	$159.82 - $182.1 $43,790 - $49,895	274 Added 1.62%	17,183 $3.13 Million
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $38,940 - $43,856	283 Added 1.7%	16,909 $2.62 Million
Q3 2023 Nov 08, 2023	SELL	$133.59 - $154.65 $56,107 - $64,953	-420 Reduced 2.46%	16,626 $2.48 Million
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $20,539 - $25,559	-155 Reduced 0.9%	17,046 $2.3 Million
Q1 2023 May 03, 2023	SELL	$144.61 - $166.54 $4,338 - $4,996	-30 Reduced 0.17%	17,201 $2.74 Million
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $139,554 - $167,362	-1,009 Reduced 5.53%	17,231 $2.79 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $86,297 - $98,976	-643 Reduced 3.41%	18,240 $2.45 Million
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $34,405 - $43,740	250 Added 1.34%	18,883 $2.89 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $159,563 - $197,973	1,209 Added 6.94%	18,633 $3.02 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $111,727 - $141,367	1,040 Added 6.35%	17,424 $2.36 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $72,032 - $81,768	677 Added 4.31%	16,384 $1.77 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $24,829 - $27,661	236 Added 1.53%	15,707 $1.77 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $34,986 - $38,516	342 Added 2.26%	15,471 $1.67 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $38,232 - $51,618	-475 Reduced 3.04%	15,129 $1.62 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $429 - $504	-5 Reduced 0.03%	15,604 $1.33 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $59,209 - $79,231	807 Added 5.45%	15,609 $1.53 Million
Q1 2020 May 05, 2020	SELL	$64.5 - $97.79 $40,506 - $61,412	-628 Reduced 4.07%	14,802 $1.25 Million
Q4 2019 Feb 06, 2020	BUY	$72.13 - $90.25 $685,379 - $857,555	9,502 Added 160.29%	15,430 $1.37 Million
Q3 2019 Nov 07, 2019	BUY	$62.98 - $75.72 $3,652 - $4,391	58 Added 0.99%	5,928 $449,000
Q2 2019 Aug 07, 2019	BUY	$65.7 - $83.98 $18,001 - $23,010	274 Added 4.9%	5,870 $427,000
Q1 2019 May 07, 2019	BUY	$77.14 - $90.79 $13,268 - $15,615	172 Added 3.17%	5,596 $451,000
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $422,258 - $520,758	5,424 New	5,424 $500,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 9258 Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 9258 Wealth Management, LLC with notifications on news.

Account

9258 Wealth Management, LLC Abb Vie Inc. Transaction History